You just read:

Jazz Pharmaceuticals Presents Data for the Phase 3 TONES 2 Study of JZP-110 in Patients with Excessive Sleepiness Associated with Narcolepsy

News provided by

Jazz Pharmaceuticals plc

Jun 06, 2017, 17:00 ET